PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

A- A+

PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

Finanznachrichten
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for
Business
Read Article